CEACAM5 and neoplasm: Improvement in serum LF level, GST, IFN-γ, tumor marker CEA, blood cells (WBC and RBC) count, renal and hepatic functions, less severe mucositis, lesser rate of infection recurrence and less incidence of fever than in control chemotherapy-treated only group